Abstract
Adenosine has received wide acceptance as the drug of choice for initial treatment of supraventricular tachycardias (SVT), and as a diagnostic adjunct in hemodynamically stable, wide-complex tachycardias. This report describes the successful use of adenosine for the treatment of SVT occurring after successful initial resuscitation from ventricular fibrillation, in which a high dose of the epinephrine protocol was used.
MeSH terms
-
Adenosine / pharmacology
-
Adenosine / therapeutic use*
-
Aged
-
Aged, 80 and over
-
Anti-Arrhythmia Agents / pharmacology
-
Anti-Arrhythmia Agents / therapeutic use*
-
Cardiopulmonary Resuscitation / adverse effects*
-
Cardiopulmonary Resuscitation / methods*
-
Electric Countershock
-
Electrocardiography
-
Emergency Medical Services
-
Epinephrine / adverse effects*
-
Heart Arrest / drug therapy*
-
Humans
-
Infusions, Intravenous
-
Male
-
Tachycardia, Supraventricular / chemically induced*
-
Tachycardia, Supraventricular / diagnosis
-
Tachycardia, Supraventricular / drug therapy*
-
Vasoconstrictor Agents / adverse effects*
-
Ventricular Fibrillation / diagnosis
-
Ventricular Fibrillation / drug therapy*
Substances
-
Anti-Arrhythmia Agents
-
Vasoconstrictor Agents
-
Adenosine
-
Epinephrine